Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature

Hum Pathol. 2008 Oct;39(10):1548-51. doi: 10.1016/j.humpath.2008.01.021. Epub 2008 Jul 11.

Abstract

An 80-year-old white man underwent pylorus-preserving pancreaticoduodenectomy after presenting with obstructive jaundice and a dilated biliary tree on cholangiopancreatography. Histologic evaluation of the specimen revealed synchronous autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis) and infiltrating ductal adenocarcinoma of the pancreas. The mixed inflammatory infiltrate centered on the pancreatic ducts was associated with acinar loss, parenchymal fibrosis, and obliterative venulitis. Immunohistochemical labeling with an antibody to IgG4 revealed greater than 50 IgG4-positive plasma cells per high power field. Although not appreciated grossly, pancreatic intraepithelial neoplasia-3 and a neurotropic infiltrating poorly differentiated adenocarcinoma of the pancreas were also present. This case highlights the importance of carefully evaluating patients with autoimmune pancreatitis to rule out an underlying neoplasm and the importance of following those who were treated nonsurgically until the disease fully resolves.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / pathology*
  • Carcinoma in Situ / complications
  • Carcinoma in Situ / metabolism
  • Carcinoma in Situ / pathology*
  • Carcinoma, Pancreatic Ductal / complications
  • Carcinoma, Pancreatic Ductal / metabolism
  • Carcinoma, Pancreatic Ductal / pathology*
  • Humans
  • Immunoglobulin G / metabolism
  • Male
  • Pancreatic Ducts / metabolism
  • Pancreatic Ducts / pathology
  • Pancreatic Neoplasms / complications
  • Pancreatic Neoplasms / metabolism
  • Pancreatic Neoplasms / pathology*
  • Pancreaticoduodenectomy
  • Pancreatitis / immunology
  • Pancreatitis / metabolism
  • Pancreatitis / pathology*
  • Plasma Cells / metabolism
  • Plasma Cells / pathology
  • Treatment Outcome

Substances

  • Immunoglobulin G